ACTU
ACTU
NASDAQ · Biotechnology

Actuate Therapeutics Inc

$4.41
+0.09 (+2.08%)
As of Feb 8, 2:11 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 11.82M 10.52M 11.40M
Net Income 3.06M 2.28M 2.66M
EPS
Profit Margin 25.9% 21.7% 23.3%
Rev Growth +9.7% +22.7% +8.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 8.56M 8.50M 10.38M
Total Equity 53.75M 65.18M 64.60M
D/E Ratio 0.16 0.13 0.16
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 4.32M 3.67M 4.36M
Free Cash Flow 3.21M 3.03M 2.01M